Global Antidepressants Market Size

Global Antidepressants Market 2022 – Market Opportunities And Strategies

The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.


The antidepressants market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 8%, as per The Business Research Company’s market report!


Read More On The Antidepressants Market Report 2022 –


The Antidepressants Market Size In 2022 And Forecast

The global antidepressants market is expected to grow from $15.61 billion in 2021 to $16.44 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The antidepressants market is expected to reach $22.57 billion in 2026 at a CAGR of 8.2%.


The antidepressants market consists of sales of antidepressants and related services that are used in retail pharmacies, hospitals and clinics.


Request for A Sample Of The Global Antidepressants Market Report:


Rising Cases Of Mental Health Disorders Is Driving The Growth Of The Antidepressants Market

For instance, the antidepressants Lexapro (escitalopram) and Celexa (citalopram), both are used to treat depression and Lexapro also helps for treating anxiety. Lexapro and Celexa can cause side effects common to others which include nausea, sleeplessness, sweating, dry mouth and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures and vision issues. Therefore, the side-effects of antidepressant drugs is expected to limit the growth of the antidepressant market.


Competitive Landscape And The Regional Analysis Of The Antidepressants Market

Major players in the antidepressants market are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, Sun Pharmaceuticals Pvt Ltd, Alkermes, Bristol Myers Squibb Company, Teva Pharmaceutical Industries, Eli Lilly and Co., Takeda Pharmaceutical Co. Ltd, Forest laboratories and Akeda Pharmaceutical.


Additionally, as per TBRC’s research – North America was the largest region in the antidepressants market in 2021 holding the largest market share and Middle East is expected to be the fastest-growing region in the forecast period.


The Antidepressants Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the antidepressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the antidepressants market.


New Treatments For Resistant Depression – A Key Trend In The Antidepressants Market

The treatment of resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviors.


Antidepressants Market Segmentation By The Business Research Company

1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)

2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants

3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder


Here Are Some Reports Related To The Antidepressants Market –

Neurodegenerative Disorder Therapeutics Global Market Report 2022

Psychedelic Drugs Global Market Report 2022

Central Nervous System Drugs Global Market Report 2022


Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708


Found this article helpful? Share it on: